1AI 10.0% 0.9¢ algorae pharmaceuticals limited

Ann: Results of LCT Parkinsons trial require further analysis, page-49

  1. 42 Posts.
    While disappointed, having bought lct in the hope of them developing a treatment fo pd ( which my wife has) there is no way I'm selling at 4c. LCT has proven technology which is worth a fair bit. Plus I think the results are a bit more less obvious than announcement indicated.I'm hanging in at least til next year
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.